21 Sep. 2005 - 27 Sep. 2005
Mergers, Acquisitions, Co operations, Licensing - weekly Overview
/ Buyer / Driver /
Acquired / Seller /
Short Activity Description / Objective
Clinical Data, Inc.
Clinical Data, Inc. and biotechnology company Icoria, Inc. announced the execution of a merger
agreement whereby Clinical Data will acquire Icoria in an all-stock transaction valued at
approximately $12.5 million based on the closing price of Clinical Data's Common Stock on
Friday, September 16. The acquisition is expected to close late this year or in early 2006,
pending approval by Icoria's shareholders. Under the terms of the agreement, Icoria shareholders
will receive 0.0139 shares of Clinical Data Common Stock for each share of Icoria Common
Stock they own.
Genaissance Pharmaceuticals, Inc. announced that it has entered into a pharmacogenomic
research collaboration with Otsuka Pharmaceutical Co., Ltd. Under the terms of the agreement,
Genaissance will apply its HAP™ Technology with the goal of identifying genetic markers related
to drug response. Genaissance and Otsuka will be co-owners of the intellectual property that
results from the collaboration and both companies will be eligible to receive royalties on revenues
generated from diagnostic products resulting from the collaboration.
Antares Pharma, Inc.
Antares Pharma, Inc. , announced that it has signed an agreement with a major Japanese
pharmaceutical company to evaluate Antares Pharma's novel Vibex™ mini-needle injection
devices for delivery of an undisclosed biopharmaceutical. The evaluation agreement provides the
Japanese company with exclusive rights to evaluate Antares' Vibex™ injector technology for the
delivery of a proprietary drug in the Japanese market during the evaluation period. The eva